Outcomes of patients diagnosed with myelodysplastic syndrome or acute myeloid leukemia following solid organ transplantation

Key Points

• To examine the outcomes of patients with myelodysplastic syndrome or acute myeloid leukemia after receiving solid organ transplants.
• Patients diagnosed with myelodysplastic syndrome or acute myeloid leukemia were selected for analysis after solid organ transplantation.
• Outcomes measured included complications and overall survival rates.
• Outcomes indicate varying rates of complications post-transplant, highlighting the risks associated with these conditions.
• Survival rates differ significantly between myelodysplastic syndrome and acute myeloid leukemia patients following transplantation.